imatinib mesylate has been researched along with Complication, Postoperative in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, K; Jiromaru, R; Matsuo, M; Nakagawa, T | 1 |
| Bonvalot, S; Casali, P; Gronchi, A; Hohenberger, P; Litiere, S; Olungu, C; Rutkowski, P; Stoeckle, E; van Coevorden, F; Wardelmann, E | 1 |
| Brosens, LAA; Gertsen, EC; Ruurda, JP; van Boxel, GI; van Hillegersberg, R | 1 |
| Baia, M; Bastiaannet, E; Desar, IME; Farag, S; Gelderblom, H; Gronchi, A; Hohenberger, P; IJzerman, NS; Jones, RL; Martin-Broto, J; Mohammadi, M; Oosten, AW; Reyners, AKL; Rutkowski, P; Schöffski, P; Schrage, Y; Steeghs, N; van Sandick, JW; Vassos, N | 1 |
| Han, X; Lin, G; Qiu, H; Xu, J | 1 |
| Huang, ML; Li, C; Liu, WT; Sah, BK; Shi, HP; Wang, ZQ; Yan, M; Zheng, YN; Zhu, ZG; Zhu, ZL | 1 |
| Bi, X; Cai, J; Chen, Q; Huang, Z; Li, C; Li, Z; Yang, H; Zhang, Y; Zhao, H; Zhao, J; Zhou, J | 1 |
| Li, WH; Li, WW; Wei, SC; Xu, L | 1 |
| Barisella, M; Casali, PG; Colombo, C; Fiore, M; Frezza, AM; Fumagalli, E; Gronchi, A; Morosi, C; Radaelli, S; Tirotta, F | 1 |
| Anzalone, CL; Cohen, PR; Cortes, JE; Kurzrock, R | 1 |
| Chung, KM; Lai, EC; Lau, SH; Lau, WY | 1 |
| Burke, MJ; Cao, Q; Kumar, A; Smith, A; Trotz, B; Verneris, MR; Weigel, B | 1 |
| Chan, WY; Chung, SC; Mok, TS; Ng, EK; Wong, SK | 1 |
| Cunningham, SC; Shibata, D; Volpe, C | 1 |
| Koskinen, PK; Krebs, R; Lemström, KB; Nykänen, AI; Raisky, O; Sihvola, R; Tikkanen, JM; Wood, J | 1 |
| Hou, M; Li, HY; Wang, Y; Zhang, J; Zhu, J | 1 |
1 trial(s) available for imatinib mesylate and Complication, Postoperative
| Article | Year |
|---|---|
Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Digestive System Surgical Procedures; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Postoperative Complications; Prognosis; Quality of Health Care; Quality of Life; Survival Rate | 2019 |
15 other study(ies) available for imatinib mesylate and Complication, Postoperative
| Article | Year |
|---|---|
Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report.
Topics: Aged; Cutaneous Fistula; Humans; Imatinib Mesylate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Molecular Targeted Therapy; Pharyngeal Diseases; Postoperative Complications; Receptors, Platelet-Derived Growth Factor; Retrospective Studies; Vascular Endothelial Growth Factor A | 2022 |
Minimally Invasive Resection of Large Gastric Gastrointestinal Stromal Tumors.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Conversion to Open Surgery; Disease-Free Survival; Female; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intraoperative Complications; Laparoscopy; Length of Stay; Male; Margins of Excision; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Postoperative Complications; Retrospective Studies; Stomach Neoplasms; Tumor Burden | 2020 |
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study.
Topics: Aged; Anastomotic Leak; Antineoplastic Agents; Biopsy, Fine-Needle; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Europe; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Margins of Excision; Middle Aged; Mitotic Index; Neoadjuvant Therapy; Neoplasm Metastasis; Plastic Surgery Procedures; Postoperative Complications; Progression-Free Survival; Retrospective Studies; Treatment Outcome; Tumor Burden | 2021 |
A Novel Curative Treatment Strategy for Patients with Lower Grade Rectal Gastrointestinal Stromal Tumor: Chemoreduction Combined with Transanal Endoscopic Microsurgery.
Topics: Adult; Aged; Antineoplastic Agents; China; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Postoperative Complications; Rectal Neoplasms; Retrospective Studies; Transanal Endoscopic Microsurgery; Treatment Outcome | 2017 |
Clinicopathological and Prognostic Features of Surgical Management in Duodenal Gastrointestinal Stromal Tumors.
Topics: Adult; Aged; Anastomosis, Surgical; Antineoplastic Agents; Chemotherapy, Adjuvant; Disease-Free Survival; Duodenal Neoplasms; Duodenum; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunum; Kaplan-Meier Estimate; Male; Middle Aged; Mitotic Index; Neoadjuvant Therapy; Neoplasm Grading; Pancreaticoduodenectomy; Postoperative Complications; Retrospective Studies; Survival Rate; Tumor Burden; Young Adult | 2018 |
Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China.
Topics: Adult; Aged; China; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Length of Stay; Liver Neoplasms; Male; Middle Aged; Postoperative Complications; Prognosis; Protein Kinase Inhibitors; Radiofrequency Ablation; Retrospective Studies; Sunitinib | 2019 |
Malignant jejunal gastrointestinal stromal tumor with history of prostate cancer: A case report.
Topics: Aged; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Neoplasm Metastasis; Peritoneal Neoplasms; Postoperative Complications; Prostatic Neoplasms; Protein Kinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Management of complicated tumor response to tyrosine-kinase inhibitors in gastrointestinal stromal tumors.
Topics: Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Incidence; Male; Middle Aged; Postoperative Complications; Protein Kinase Inhibitors; Retrospective Studies; Sunitinib | 2019 |
Imatinib-induced postoperative periorbital purpura: GASP (Gleevec-Associated Surgical Purpura) in a woman with imatinib-treated chronic myelogenous leukemia.
Topics: Aged; Antineoplastic Agents; Benzamides; Blepharoplasty; Drug Administration Schedule; Ecchymosis; Edema; Eyelid Diseases; Female; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Postoperative Complications; Postoperative Hemorrhage; Preoperative Care; Protein Kinase Inhibitors; Purpura; Pyrimidines; Retrospective Studies; Skin Transplantation | 2014 |
A ruptured recurrent small bowel gastrointestinal stromal tumour causing hemoperitoneum.
Topics: Antineoplastic Agents; Benzamides; Cytoreduction Surgical Procedures; Disease Progression; Dissection; Dose-Response Relationship, Drug; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hemoperitoneum; Humans; Imatinib Mesylate; Intestine, Small; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Postoperative Complications; Pyrimidines; Risk Assessment; Rupture, Spontaneous | 2015 |
Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Humans; Imatinib Mesylate; Immunosuppressive Agents; Infant; Male; Piperazines; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2009 |
Imatinib (STI-571) heals a gastrocutaneous fistula resulting from a malignant gastric stromal tumor.
Topics: Benzamides; Cutaneous Fistula; Gastric Fistula; Humans; Imatinib Mesylate; Laparotomy; Magnetic Resonance Imaging; Male; Middle Aged; Piperazines; Postoperative Complications; Pyrazoles; Pyrimidines; Stomach Neoplasms; Tomography, X-Ray Computed | 2003 |
Isolated abdominal wound metastasis from a gastrointestinal stromal tumor.
Topics: Abdominal Wall; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Digestive System Surgical Procedures; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Laparoscopy; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Postoperative Complications; Pyrimidines; Stromal Cells; Surgical Wound Dehiscence | 2003 |
Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
Topics: Angiogenesis Inhibitors; Animals; Arteriosclerosis; Benzamides; Graft Rejection; Heart Transplantation; Imatinib Mesylate; Inflammation; Male; Muscle, Smooth, Vascular; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Postoperative Complications; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Inbred WF; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pilot Projects; Piperazines; Postoperative Complications; Pyrimidines | 2007 |